Return to API China in Guangzhou for 2025

Wasserburg, Germany: – Pharmaceutical excipient industry leader MEGGLE will again be a double presence at the major API China Expo for 2025 in Guangzhou.

MEGGLE has been a consistent presence at the API China show, which in under a decade has firmly established itself as a central event for the huge Chinese pharmaceutical industry and by extension for the industry worldwide.

Standard Pharma and Pintect

MEGGLE lactose-based excipients will again be displayed at the Guangzhou’s China Import and Export Complex CIEC Center, via its regional partner Standard Pharma at Booth 10.2 G01. The other partner of MEGGLE Pintect Pharma will also be present at the event.

Professionals from MEGGLE’s Shanghai bureau will be present on the Standard Pharma stand to connect with industry professionals and answer technical questions about lactose excipient applications and solutions for DPI (Dry Powder Inhalation), direct compression (DC), and co-processed formulations.

Leaders of the excipients industry

The team will also take advantage of the show’s networking opportunities to connect with new customers and explore new potential cooperations that leverage the effectiveness of its high-quality lactose-based excipients in meeting evolving and emerging needs in pharmaceutical oral solid dose formulations.

MEGGLE Pharma has a long-standing reputation for excellence in the production of pharmaceutical excipients, with a strong commitment to quality, innovation, and customer support. Its consistent presence at API China underlines its dedication to serving the pharmaceutical industry worldwide, reinforcing the message that ‘The world of lactose is the world of MEGGLE’.

About MEGGLE Wasserburg

Bavarian-based company MEGGLE is one of the world’s experts in co-processing and powder technology. From its roots as a dairy operation in the late 1880’s, MEGGLE has become one of the world’s leading manufacturers of pharmaceutical grade lactose, supplying the pharmaceutical industry with a broad-based and unique lactose product portfolio.

MEGGLE’s Business Unit Excipients has harnessed outstanding product quality and intelligent innovation to become a global leader in the manufacture of lactose-based excipients, focusing on products for direct tableting and dry powder inhalation.

A multidisciplinary team of committed and highly qualified people allows MEGGLE clients to benefit from pioneering experience and innovation in industrial milk and whey processing. The company constantly strives to develop high-technological, functional products for solid dosage forms and DPI applications, where they can deliver maximum performance.

The company has introduced several revolutionary products, notably Tablettose®, the world’s first agglomerated pharmaceutical lactose grade for direct tableting, Cellactose® 80, a pioneering co-processed excipient based on powdered cellulose and lactose for outstanding compression and flow properties and RetaLac®, the first direct compressible co-processed excipient using Hypromellose and lactose for sustained release formulations.

To learn more, visit: https://www.meggle-pharma.com

About API China 2025

Founded in 2016, the API China expo has expanded to become one of Asia’s premier pharmaceutical trade shows. The main show covers some 50,000 active ingredients organized in more than 20 distinct categories, reflecting China’s prominence as a major world supplier.

API China is based on a huge B2B platform for trading, knowledge sharing, exchange and cooperation and with application fields that include ingredient and excipient sourcing, pharma and biotech R & D, engineering design, manufacturing, and packaging.

API China 2025 is a three-day event opening May 21 at the China Import and Export Complex in Guangzhou. The 2025 show is expected to attract more than 1,000 exhibitors and some 70,000 visitors.

The event incorporates three co-located exhibitions: PharmEx for ingredients and excipients, PharmPack for packaging machinery and Sinophex for pharmaceutical equipment. Once again, API China will be collocated with PHARMCHINA and China International Natural Health & Nutrition Expo (NHNE), creating a comprehensive platform that interacts with the pharmaceutical and health nutrition industry chain.

The event is organized by API China with further information at: https://www.apichina.com.cn

Resources

Click on MEGGLE Product Configurator for further information.
Click on MEGGLE Company Overview to learn more